Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Charlotte S Voskuilen"'
Autor:
Nick van Dijk, Alberto Gil-Jimenez, Karina Silina, Maurits L. van Montfoort, Sarah Einerhand, Lars Jonkman, Charlotte S. Voskuilen, Dennis Peters, Joyce Sanders, Yoni Lubeck, Annegien Broeks, Erik Hooijberg, Daniel J. Vis, Maries van den Broek, Lodewyk F. A. Wessels, Bas W. G. van Rhijn, Michiel S. van der Heijden
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Candidate immune biomarkers have been proposed for predicting response to immunotherapy in urothelial cancer (UC). Yet, these biomarkers are imperfect and lack predictive power. A comprehensive overview of the tumor immune contexture, including Terti
Externí odkaz:
https://doaj.org/article/8fafb947107347b58fd43347731cd2e1
Autor:
Sarah M.H. Einerhand, Charlotte S. Voskuilen, Elies E. Fransen van de Putte, Maarten L. Donswijk, Annemarie Bruining, Michiel S. van der Heijden, Laura S. Mertens, Kees Hendricksen, Erik Vegt, Bas W.G. van Rhijn
Publikováno v:
Bladder Cancer, 9(1), 49-57. IOS Press
Einerhand, S M H, Voskuilen, C S, van de Putte, E E F, Donswijk, M L, Bruining, A, van der Heijden, M S, Mertens, L S, Hendricksen, K, Vegt, E & van Rhijn, B W G 2023, ' Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer ', Bladder Cancer, vol. 9, no. 1, pp. 49-57 . https://doi.org/10.3233/BLC-220036
Einerhand, S M H, Voskuilen, C S, van de Putte, E E F, Donswijk, M L, Bruining, A, van der Heijden, M S, Mertens, L S, Hendricksen, K, Vegt, E & van Rhijn, B W G 2023, ' Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer ', Bladder Cancer, vol. 9, no. 1, pp. 49-57 . https://doi.org/10.3233/BLC-220036
BACKGROUND: Neoadjuvant/induction chemotherapy (NAIC) improves survival in patients with muscle-invasive bladder carcinoma (MIBC). On-treatment response assessment may aid in decisions to continue or cease NAIC. OBJECTIVE: We investigated whether 18F
Autor:
Peter C. Black, Jonathan L. Wright, Michiel S. van der Heijden, Marc Dall'Era, Joost L. Boormans, Elai Davicioni, George N. Thalmann, Ellen C. Zwarthoff, Elisabeth E. Fransen van de Putte, Bas W.G. van Rhijn, Simon J. Crabb, Funda Vakar-Lopez, James Douglas, Mandeep M. Takhar, Nicholas Erho, Brian Winters, Charlotte S. Voskuilen, Kim E. van Kessel, Hung-Ming Lam, Htoo Zarni Oo, Natalie Q. Wang, Ewan A. Gibb, Roland Seiler
Table S1-S5 Figures S1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::391e26dedee4c196766fda6e68cb78b6
https://doi.org/10.1158/1078-0432.22472909
https://doi.org/10.1158/1078-0432.22472909
Autor:
Peter C. Black, Jonathan L. Wright, Michiel S. van der Heijden, Marc Dall'Era, Joost L. Boormans, Elai Davicioni, George N. Thalmann, Ellen C. Zwarthoff, Elisabeth E. Fransen van de Putte, Bas W.G. van Rhijn, Simon J. Crabb, Funda Vakar-Lopez, James Douglas, Mandeep M. Takhar, Nicholas Erho, Brian Winters, Charlotte S. Voskuilen, Kim E. van Kessel, Hung-Ming Lam, Htoo Zarni Oo, Natalie Q. Wang, Ewan A. Gibb, Roland Seiler
Purpose:After cisplatin-based neoadjuvant chemotherapy (NAC), 60% of patients with muscle-invasive bladder cancer (MIBC) still have residual invasive disease at radical cystectomy. The NAC-induced biological alterations in these cisplatin-resistant t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e1bd166f8e23767cd65631923347188
https://doi.org/10.1158/1078-0432.c.6528368.v1
https://doi.org/10.1158/1078-0432.c.6528368.v1
Autor:
Andrew S. Mason, Thomas van Doeveren, Angelique C. van der Made, Job van Riet, Geert J.L.H. van Leenders, Antoine G. van der Heijden, Harmen J.G. van de Werken, Kees Hendricksen, Joost L. Boormans, Charlotte S. Voskuilen, Tahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Bas W.G. van Rhijn, Jose A Nakauma-Gonzalez, Isabelle C. Meijssen, Hendrikus J. Dubbink, Winand N.M. Dinjens
Publikováno v:
International Journal of Cancer, 148(4), 981-987. Wiley-Liss Inc.
International Journal of Cancer, 148, 4, pp. 981-987
International Journal of Cancer
International Journal of Cancer, 148, 981-987
International Journal of Cancer, 148, 4, pp. 981-987
International Journal of Cancer
International Journal of Cancer, 148, 981-987
The risk of developing urothelial carcinoma of the bladder (UCB) in patients treated by radical nephroureterectomy (RNU) for an upper urinary tract urothelial carcinoma (UTUC) is 22% to 47% in the 2 years after surgery. Subject of debate remains whet
Autor:
Laura S. Mertens, S. Einerhand, Henk G. van der Poel, Kees Hendricksen, Annemarie Bruining, E. Vegt, Maarten L. Donswijk, Erik J. van Gennep, Simon Horenblas, Charlotte S. Voskuilen, Bas W.G. van Rhijn
Publikováno v:
European Urology Oncology, 5(3), 366-369. Elsevier BV
Voskuilen, C S, van Gennep, E J, Einerhand, S M H, Vegt, E, Donswijk, M L, Bruining, A, van der Poel, H G, Horenblas, S, Hendricksen, K, van Rhijn, B W G & Mertens, L S 2022, ' Staging 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer ', European Urology Oncology, vol. 5, no. 3, pp. 366-369 . https://doi.org/10.1016/j.euo.2021.01.005
European urology oncology, 5(3), 366-369. Elsevier
Voskuilen, C S, van Gennep, E J, Einerhand, S M H, Vegt, E, Donswijk, M L, Bruining, A, van der Poel, H G, Horenblas, S, Hendricksen, K, van Rhijn, B W G & Mertens, L S 2022, ' Staging 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer ', European Urology Oncology, vol. 5, no. 3, pp. 366-369 . https://doi.org/10.1016/j.euo.2021.01.005
European urology oncology, 5(3), 366-369. Elsevier
Given the high risk of systemic relapse following initial therapy for muscle-invasive bladder cancer (MIBC), improved pretreatment staging is needed. We evaluated the incremental value of 18F-fluorodeoxyglucose positron emission tomography/computed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cac4d2eb8e1cc60fb4b3adb8ca3f7ad4
https://research.vumc.nl/en/publications/8bd95d20-f060-4a42-ac1b-4c08acfd0941
https://research.vumc.nl/en/publications/8bd95d20-f060-4a42-ac1b-4c08acfd0941
Autor:
Atiqullah Aziz, Matteo Soligo, Giuseppe Simone, Andrea Gallina, Luca Afferi, Evanguelos Xylinas, Ottavio De Cobelli, Alberto Briganti, Shahrokh F. Shariat, Michael Rink, Claudio Simeone, R. Jeffrey Karnes, Charlotte S. Voskuilen, Francesco Montorsi, Agostino Mattei, Mario Alvarez-Maestro, Marco Moschini, Gerald Schulz, Ettore Di Trapani, Stefania Zamboni, Luis Martínez-Piñeiro, Mohammad Abufaraj, Florian Roghmann, Gabriele Tuderti, Kees Hendricksen, Paul Sargos, Cédric Poyet
Publikováno v:
World Journal of Urology. 39:443-451
Purpose: To assess the impact of perioperative chemotherapy on survival in cN+ BCa patients and analyze it according to the pN status. Methods: A retrospective analysis was conducted on639 BCa patients with cTanyN1-3M0 BCa treated with radical cystec
Autor:
Luc M.F. Moonen, Bradley R. Pieters, Axel Bex, M. Burger, Kees Hendricksen, H.G. van der Poel, André N. Vis, Floris J. Pos, Judith Bosschieter, B.W.G. Van Rhijn, E. van Werkhoven, Charlotte S. Voskuilen, S. Horenblas, Jakko A. Nieuwenhuijzen
Publikováno v:
Radiotherapy and Oncology. 158:S70-S72
Autor:
Wim Meinhardt, Axel Bex, Charlotte S. Voskuilen, M L Korbee, Max Bürger, Simon Horenblas, Kees Hendricksen, Esther Wit, Roman Mayr, H.G. van der Poel, B.W.G. van Rhijn, P. J. van Leeuwen
Publikováno v:
World Journal of Urology. 38:2197-2205
Radical cystectomy (RC) is associated with substantial postoperative mortality. In this study, we analyzed early (30-day; 30 M) and late (30–90-day; 30–90 M) mortality after RC in a Dutch tertiary referral center and determined factors associated
Autor:
Ewan A. Gibb, Nicholas Erho, Jonathan L. Wright, George N. Thalmann, Natalie Q. Wang, Brian Winters, Marc A. Dall'Era, Hung-Ming Lam, M. Takhar, Elisabeth E. Fransen van de Putte, Funda Vakar-Lopez, Michiel S. van der Heijden, Elai Davicioni, Bas W.G. van Rhijn, Roland Seiler, Peter C. Black, Htoo Zarni Oo, Simon J. Crabb, Kim E.M. van Kessel, Charlotte S. Voskuilen, Ellen C. Zwarthoff, Joost L. Boormans, James Douglas
Publikováno v:
Clinical Cancer Research, 25(16), 5082-5093. American Association for Cancer Research Inc.
Seiler, Roland; Gibb, Ewan A; Wang, Natalie Q; Oo, Htoo Zarni; Lam, Hung-Ming; Van Kessel, Kim E; Winters, Brian; Erho, Nicholas G; Takhar, Mandeep M; Douglas, James; Vakar-Lopez, Funda; van Rhijn, Bas W G; Fransen van de Putte, Elisabeth E; Zwarthoff, Ellen C; Thalmann, George; Boormans, Joost L; Dall'Era, Marc; van der Heijden, Michiel S; Wright, Jonathan L and Black, Peter C (2019). Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Clinical cancer research, 25(16), pp. 5082-5093. American Association for Cancer Research 10.1158/1078-0432.CCR-18-1106
Seiler, Roland; Gibb, Ewan A; Wang, Natalie Q; Oo, Htoo Zarni; Lam, Hung-Ming; Van Kessel, Kim E; Winters, Brian; Erho, Nicholas G; Takhar, Mandeep M; Douglas, James; Vakar-Lopez, Funda; van Rhijn, Bas W G; Fransen van de Putte, Elisabeth E; Zwarthoff, Ellen C; Thalmann, George; Boormans, Joost L; Dall'Era, Marc; van der Heijden, Michiel S; Wright, Jonathan L and Black, Peter C (2019). Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Clinical cancer research, 25(16), pp. 5082-5093. American Association for Cancer Research 10.1158/1078-0432.CCR-18-1106
Purpose: After cisplatin-based neoadjuvant chemotherapy (NAC), 60% of patients with muscle-invasive bladder cancer (MIBC) still have residual invasive disease at radical cystectomy. The NAC-induced biological alterations in these cisplatin-resistant